This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers, clinicians and innovators. The series will help attendees anticipate, access, and apply new approaches and technologies for patient care.
The Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
To register, click the button below or go to https://us06web.zoom.us/webinar/register/WN_MzE5qgCSQCyPI-X9Ys7_IQ
2024-2025 Leading Strand from 12:00pm – 1:00pm ET, scheduled dates are:
Friday September 27, 2024
Friday October 25, 2024
Friday November 22, 2024
Friday December 13, 2024 – cancelled
Friday, January 31, 2025
Friday February 28, 2025
Genome Mapping – From Development to Clinical Implementation
Optical Genome Mapping is a non-sequencing based technology that can be used to analyze genomes for structural variation at high resolution. This technology can replace or supplement current cytogenetic techniques such as karyotype, FISH and chromosomal microarray. The presentation will review how Optical Genome Mapping has been used to better define structural variation in hematologic malignancies in clinical samples as well as applications in pre- and post-natal cytogenetics.
Learning Objectives:
- Compare the strengths and limitations of genome mapping techniques for the detection of genome wide structural variants.
- Consider the changes in clinical practice with the application of new high resolution technologies.
Speaker: Dr. Adam Smith
Bio: Dr. Smith is a dual-boarded Clinical Cytogeneticist and Clinical Molecular Geneticist certified by the Canadian College of Medical Geneticists (CCMG). Dr. Smith is also a fellow of the American College of Genetics and Genomics (FACMG) and a Certified Laboratory Geneticist (erCLG) by the European Board of Medical Genetics.
Dr. Smith completed his Master’s degree and Ph.D. at the University of Toronto. Dr. Smith is currently a Clinical Laboratory Director at Labcorp. He is also an internationally recognized leader in the implementation of Optical Genome Mapping in a clinical setting. Dr. Smith received the CCMG Genetics and Genomics Award for Innovation (2024) for his work in Optical Genome Mapping.
Friday, March 28, 2025
Friday, April 25, 2025
Friday, May 30, 2025
Friday June 27, 2025
Friday, May 16, 2025
Friday, June 20, 2025